HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 215.83 billion as of October 31, 2025. Its market cap has decreased by -41.11% in one year.

Market Cap

215.83B

Enterprise Value

203.48B

Revenue

36.10B

Ranking

n/a

PE Ratio

456.63

Stock Price

15,370.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 215.83B, an increase of 156.09%. That is a compound annual growth rate of 10.00%.

Market Cap History

Date	Market Cap	% Change
Oct 30, 2025	218.92B	-35.31%
Dec 30, 2024	338.42B	58.45%
Dec 28, 2023	213.58B	43.49%
Dec 29, 2022	148.85B	-21.48%
Dec 30, 2021	189.57B	-21.05%
Dec 30, 2020	240.12B	219.34%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro
Dec 21, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	87.69T
Celltrion	39.50T
ALTEOGEN	25.46T
SK Biopharmaceuticals	9.08T
Yuhan	8.94T
HLB Co., Ltd.	6.25T
Peptron	6.06T
PharmaResearch	5.57T

Market Cap Rankings